Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Plaintiff Ruby R. has filed a Taxotere lawsuit in Louisiana federal court against the manufacturers of chemotherapy drug Taxotere. She alleges Taxotere caused her to suffer permanent hair loss, also known as permanent alopecia.
Defendants named in the chemotherapy drug lawsuit include Sanofi S.A. and Aventis Pharma S.A.
Ruby states that she first started using Taxotere in February 2007 and stopped its use for chemotherapy treatment in June 2007.
Her Taxotere lawsuit raises claims for Strict Products Liability-Failure to Warn, Negligence, Negligent Misrepresentation, Fraudulent Misrepresentation, Fraudulent Concealment, and Fraud and Deceit.
Chemotherapy Drug Lawsuit Joins MDL
Ruby’s claim is filed as part of a large multidistrict litigation, or MDL, centered on allegations that the use of Taxotere as a chemotherapy drug causes disfiguring permanent alopecia.
Taxotere is also known as docetaxel. It has been extensively used in different forms to treat breast cancer , and is also used to treat stomach, prostate, head, and neck cancer.
Taxotere was designed to stop the development of cancer cells and prevent them from spreading to different areas of the body. However, allegations against Taxotere’s manufacturers purport that the drug causes permanent hair loss in patients, also known as permanent alopecia.
Permanent Alopecia Due to Taxotere
Most patients understand that there are side effects to cancer treatment, including hair loss. However, they also understand that these side effects will be temporary and may typically last anywhere between three to six months. Patients who have used Taxotere as a chemotherapy treatment drug report suffering permanent hair loss after its use.
Taxotere was manufactured and developed by Sanofi Aventis Pharmaceuticals. It was approved by the U.S. Food and Drug Administration in 1996. An increasing number, however, of patients using Taxotere have suffered irreversible and permanent hair loss as a side effect to the drug.
In a study conducted by the National Cancer Research Institute, researchers found that 10-15% of patients taking Taxotere developed permanent hair loss. In addition, several of these participants tried using different kinds of hair remedies to help re-grow and restore hair, but nothing was able to restore the damage.
A second study was also published in the Annals of Oncology. Researchers there discovered cases of permanent alopecia among women who underwent treatment for breast cancer using Taxotere. According to the study, researchers ruled out variables such as thyroid disorders and mineral deficiencies that may cause alopecia. All but one of the women had no history of the condition.
The Chemotherapy Drug Lawsuit is Case No. 2:17-cv-10073-KDE-MBN and is part of the Taxotere MDL In re: Taxotere (Docetaxel) Products Liability Litigation, MDL No 2740, in the U.S. District Court for the Eastern District of Louisiana.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Taxotere class action lawsuit is best for you. [In general, Taxotere lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Taxotere Class Action Lawsuit Investigation
If you received intravenous chemotherapy treatment for breast cancer and were told that your hair would grow back but it never did, you may have a legal claim. Permanent hair loss is defined as a minimum of 6 months after the Taxotere chemotherapy treatment ended, and there is still no new hair growth. Join this free Taxotere class action lawsuit investigation now!
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Please Note:Â If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client, if you qualify, or getting you dropped as a client.
Oops! We could not locate your form.